Frank J. Lanza - 22 Nov 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Principal Fin. & Acctng Ofc.
Signature
/s/ Frank J. Lanza
Issuer symbol
N/A
Transactions as of
22 Nov 2022
Net transactions value
$0
Form type
4
Filing time
29 Nov 2022, 15:06:22 UTC
Previous filing
19 Sep 2022
Next filing
26 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +86,438 $0.000000 86,438 22 Nov 2022 Common Stock 86,438 $0.6970 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the stock options vest every six months over two years measured from the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.